Observational therapeutics: Scope, challenges, and organization

Journal of Ayurveda and Integrative Medicine

Volumn 2, Issue 4, 2011, Pages 165-169

  Vaidya, Rama ^a  

^a Genetic Research Centre India   (India)

Author keywords

Evidence based medicine; hierarchy of evidence; observational studies

Indexed keywords

BROMOCRIPTINE; HERBACEOUS AGENT; METHYLDOPA; NAPROXEN; ROFECOXIB;

AMENORRHEA; ARTICLE; CARDIOVASCULAR DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EVIDENCE BASED MEDICINE; GALACTORRHEA; GASTROINTESTINAL DISEASE; HEART INFARCTION; HUMAN; NEUTROPENIA; OBSERVATIONAL STUDY; PARKINSON DISEASE; PARKINSONISM; PEPTIC ULCER; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROLACTINOMA; RAUWOLFIA; TINOSPORA CORDIFOLIA; TREATMENT PLANNING; VISUAL FIELD DEFECT;

EID: 84855222263     PISSN: 09759476     EISSN: 09762809     Source Type: Journal    
DOI: 10.4103/0975-9476.90764     Document Type: Article

References (47)

1. Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoSMed 2008;5:e67.
2. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs.N Engl J Med 2000; 342:1887-189.
3. Guyatt GH, Rennie D. The evidence-based medicine working group. Users' guides to the medical literature: A manual for evidence-based clinical practice. Chicago: American Medical Association Press; 2002.
4. Harrisona GW. Randomisation and Its Discontents. J Afr Econ 2011;20:626-52.
5. Vaidya RA, Pandey SN. Estrogen therapy /hormone therapy: Post women's health initiative study dilemma, debate, and emerging consensus. ECAB CLINICAL UPDATE: Obstet Gynecol 2008;2:11-52.
6. Croft P, Malmivaara A, van Tulder M. The pros and cons of evidence-based medicine. Spine 2011;36:E1121-5.
7. Martin K, Bégaud B, Latry P, Miremont-Salamé G, Fourrier A, Moore N. Differences between clinical trials and postmarketing use. Br J Clin Pharmacol 2004;57:86-92. (Pubitemid 38071811)
8. Grossman J, Mackenzie FJ. The randomized controlled trial: Gold standard, or merely standard? Perspect Biol Med 2005;48:516-34. (Pubitemid 41464107)
9. Ligthelm RJ, Borzì V, Gumprecht J, Kawamori R, Wenying Y, Valensi P. Importance of observational studies in clinical practice. Clin Ther 2007;29:1284-92. (Pubitemid 351181208)
10. Krishnan E, Fries JF. Measuring effectiveness of drugs in observational databanks: Promises and perils. Arthritis Res Ther 2004;6:41-4. (Pubitemid 38444460)
11. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334:349-51. (Pubitemid 46328045)
12. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004;363:1728-31. (Pubitemid 38670333)
13. Grimes DA, Schul KF. Bias and causal associations in observational research. Lancet 2002;359:248-52. (Pubitemid 34113828)
14. Prescription Drug User Fee Act (PDUFA). US Food and Drug Administration of US Health Services -Official Website. Available from http://www.fda.gov/ forindustry/userfees/prescriptiondruguserfee/default.htm. [Last accessed on on 2011 Sep 27].
15. Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ. The safety of newly approved medicines: Do recent market removals mean there is a problem? JAMA 1999;281:1728-34. (Pubitemid 29226484)
16. Barclay L. Reform of postmarketing drug surveillance system needed. Medscape Medical News Nov. 30 2004
17. Roden DM. An unrecognized challenge in evaluating postmarketing drug safety. Circulation 2005;111:246-8. (Pubitemid 40165326)
18. Satoskar RS. Personal communication. 2005
19. Ware WR. The Vioxx Saga: Perspective on the Recall. International health news. Issue 153, December 2004. Available from: http://www.yourhealthbase.com/ Vioxx.htm [Last accessed on 2011 Nov 02].
20. Garrard E. Practical Approaches to lifecycle signal detection. Using the right tools to develop an ideal signal management system. FDA pharmaceutical and medical device training and conferences. Available from: http://www.fdanews. com/ext/files/Conference/RMDSS10presentations/Garrard- Practical%20Approaches%20to%20Lifecycle%20 Signal%20Detection.pdf [Last accessed on 2011 Mar 22].
21. Hoppe DJ, Schemitsch EH, Morshed S, Tornetta P 3rd, Bhandari M. Hierarchy of Evidence: Where observational studies fit in and why we need them. J Bone Joint Surg Am 2009;91:2-9.
22. Desai VG. Kadu (Picrorhiza kurroa) in Aushadhi Sangraha. Vol 1. Jadhavji Trikamji Acharya.
23. Sen G, Bose K. Rauwolfia serpentina, a new Indian drug for insanity and hypertension. Indian Med World 1931;21:194-201.
24. Vaidya MS. Hadakavana ilajne vadhu pushti (More support for the remedy cited for hydrophobia). Vaidyakalpataru 1925;25:247-8.
25. Schwartz SA. Therapeutic intent and the art of observation. Jan 2009. Available from: http://www.schwartzreport.net/showarticle.php?id=6905 [Last accessed on 2011 Nov 02].
26. Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show theway forward? Drug Discov Today 2009;14:804-11.
27. Vaidya AD. Reverse pharmacological correlates of ayurvedic drug actions. Indian J Pharmacol 2006;38:311-5. (Pubitemid 44546365)
28. Patwardhan B, Vaidya AD, Chorghade M, Joshi SP. Reverse pharmacology and systems approaches for drug discovery and development. Curr Bioactive Compounds 2008;4:201-12.
29. Vaidya RA, Vaidya AD, Patwardhan B, Tillu G, Rao Y. Ayurvedic pharmacoepidemiology: A proposed new discipline. J Assoc Physicians India 2003;51:528. (Pubitemid 41315539)
30. Vaidya AD. Reverse pharmacology -A paradigm shift for new drug discovery based on Ayurvedic epistemology. In Ayurveda in Transition. Arya Vaidya Pharmacy. Kottakal 2010
31. Thatte UM, Rao SG, Dahanukar SA. Tinospora cordifolia induces colony stimulating activity in serum. J Postgrad Med 1994;40:202-3.
32. Schiffman FJ. Morning report and work rounds: Opportunities for teaching and learning. Trans Am Clin Climatol Assoc 1995;107:275-86.
33. Miller G. In first Weill Cornell grand rounds, Dr. Skorton calls for greater collaboration and research into social aspects of medicine. Chronicle Online of Cornell University. 2007 Available from: http://www.news.cornell.edu/ stories/Jan07 /skorton.grandrounds.html [Last accessed on 2011 Nov 02].
34. Pathak N, Raut A, Vaidya AB. Acute cervical pain syndrome resulting from suppressed sneezing. J Assoc Physicians India 2008;56:728-9.
35. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med 2001;134:330-4. (Pubitemid 32163956)
36. Nanal V. Are educational reforms needed? Ayurveda education Plenary Lecture-2, in Conclave proceedings. "Transforming traditions for tomorrow's health" Bhatt NS, editor. 2007. p. 36-40.
37. Shringi M, Vaidya R, Gogate J. Prolactin producing tumors in post menopausal patients-"Infrequent or Infrequently recognized". Fertil Steril 1998;69:603-5. (Pubitemid 28146580)
38. Thatte U. Editorial. Int J Ayurveda 2011;2:1.
39. Patwardhan B. Ayurveda and integrative Medicine: Riding a tiger. J Ayurveda Integr Med 2010;1:13-5.
40. Rothrock N, Kaiser KA, Cella D. Developing a valid patient-reported outcome measure. Clin Pharmacol Ther 2011;9:737-42.
41. Vaidya AD. An advocacy for Vaidya-Scientists in Ayurvedic research. J Ayurveda Integr Med 2010;1:6-8.
42. Raha S. A critique of statistical hypothesis testing in clinical research. J Ayurveda Integr Med 2011;2:105-14.
43. vanWyck JJ, Grumbach MM. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism. An example of hormonal overlap in pituitary feed back. J Pediatr 1960;57:416.
44. Vaidya RA, Vaidya AB, Van Woert MH, Kase NG. Galactorrhea and Parkinson-like syndrome: An adverse effect of alphamethyldopa. Metabolism 1970;19:1068-70.
45. Vaidya RA, Aloorkar SD, Rege NR, Maskati BT, Jahangir RP, Sheth AR, et al. Normalization of visual fields following bromocryptine treatment in hyperprolactinaeimic patients with visual field defects. Fertil Steril 1978;29:632-6.
46. Vaidya AB, Vaidya RA. Roots of modern drugs in Reverse Pharmacology. Med Update 2010;20:871-4.
47. Jain S, Murthy P. The other Bose: An account of missed opportunities in the history of neurobiology in India. Curr Sci 2009;97:266-9.